Yongin-si, South Korea

Duckhyang Shin

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Duckhyang Shin: Innovator in Biotechnology

Introduction

Duckhyang Shin is an accomplished inventor based in Yongin-si, South Korea, known for his significant contributions to the field of biotechnology. With a portfolio of two patents, Shin focuses on innovative solutions that can enhance vaccine production and improve drug delivery systems.

Latest Patents

His latest patents include the following groundbreaking innovations:

1. **MDCK-derived cell strain suspension-cultured in protein-free medium and method for proliferating virus using cell strain**: This invention relates to a novel MDCK-derived cell line that can be suspension-cultured in a protein-free medium. It provides a method for proliferating viruses, which is essential for vaccine production. The unique MDCK-derived cell line demonstrates high and uniform productivity for various viruses while minimizing viral antigenic variations and exhibiting low tumorigenicity, making it extremely valuable for vaccine development.

2. **Liposome for liver-specific delivery and release of therapeutic nucleic acids or drugs**: This patent discloses a composite designed to deliver therapeutic agents selectively to the liver. The nanoscale particle size of the composite enables the specific delivery and controlled release of therapeutic nucleic acids or drugs into hepatic cells, enhancing the therapeutic effectiveness of these agents. The composition combines an apolipoprotein A-1 with a liposome-forming material and includes a pharmaceutically acceptable carrier for optimal function.

Career Highlights

Duckhyang Shin has worked at notable organizations such as the Mogam Biotechnology Institute and the Mogam Biotechnology Research Institute. His experience in these institutions has contributed significantly to his expertise and innovations in biotechnological applications.

Collaborations

Throughout his career, Shin has collaborated with influential colleagues including Mihee Hwang and Kukjin Park. These partnerships have fostered an environment of innovation and have been instrumental in the development of his patented technologies.

Conclusion

Duckhyang Shin is a pivotal figure in the field of biotechnology, with a focus on improving vaccine production and targeted drug delivery systems. His innovative patents reflect a commitment to advancing medical technology and enhancing patient outcomes through his pioneering work.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…